The future of ethambutol and capreomycin in the chemotherapy of tuberculosis.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol